immunophenotype Flashcards
HLA-DR, S100, CD1a (+)
Langerhans Cell Histiocytosis
NNon-specific esterase only
AML, NOS, M5
myeloid antigens
AML, NOS, M0
TdT+
ALL (acute lymphoblastic leukemia)
CLA
CR4
CCR10
Mycosis Fungoides & Sezary Syndrome
CD 5, 19, 20, 23 (+)
C/SLL (chronics,small lymphocytic leukemia)
CD30
Anaplastic Large Cell Lymphoma
CD20 (+) Surface Ig (+) (IgM)
lymphoplasmacytic lymphoma
CD 10, 19, 20 (+) BCL6 (+) Surface IgM (+) BCL2 (-)* C-MYC (+)*
burkitt lymphoma
CD19, PAX5, CD10 (- if immature), CD20 and IgM (in late)
B-ALLs
CD 19, 20 (+)
Variable expression of CD10 and BCL6.
Most have surface Ig.
DLBCL (diffuse large B cell lymphoma)
No CD21 (B-cell EBV receptor)
No CD3
No TCR rearrangements
Express NK cell markers
Extranodal NK/T-cell Lymphoma
MPO
Non-specific esterase
AML, NOS, M4 (AMML)
CD 2, 3, 5 and either αβ or γδ TCRs
Peripheral T-cell Lymphoma, Unspecified
CD3
Large Granular Lymphocytic Leukemia: T-cell variant
Low levels of surface Ig (IgM +/ IgD)
C/SLL (chronics,small lymphocytic leukemia)
CD138 (+) (syndecan-1).
May be CD56 (+).
Have monoclonal spikes: only IgG and k
multiple myeloma (plasma cell myeloma)
CD20, BCL6 (unique).
No CD 15, 30
Hodgkin Lymphoma: Lymphocyte Predominance Subtype
Increased cyclin D1 CD 5, 19, 20 (+) CD 23 (-). Elevated surface Ig (usually IgM and IgD with κ or λ light chain) IgH lacks somatic hypermutation
mantle cell lymphoma (MCL)
CD1, CD2, CD5, CD7
–CD3, CD4, CD8: - in immature, + in mature
T-ALLs
MPO
CD34 , 64, 3, 15
AML, NOS, M1
CD 10, 19, 20 (+) CD5 (-) BCL6 (+) BCL2 (+) Surface Ig (+)
follicular lymphoma
CD 11c, 19, 20, 25, 103 (+)
Annexin A1
Surface Ig (IgG) (+)
hairy cell leukemia
CD56
Large Granular Lymphocytic Leukemia: NK-cell variant
PAX5 (+)
CD 15, 30 (+)
Hodgkins lymphana classical type: o Nodular sclerosis o Mixed cellularity o Lymphocyte rich o Lymphocyte depleted
CCR6, CCR7
Immunophenotype of Langerhans cell histiocytosis